Pricing in the pharmaceutical industry in the United Kingdom and the United States

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Issues in pharmaceutical economics
1. Verfasser:	Reekie, W. Duncan (VerfasserIn)
Format:	UnknownFormat
Veröffentlicht:	1979
Schlagworte:
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Titel	Jahr	Verfasser
Pricing in the pharmaceutical industry	1979	Weston, J. Fred
The history of drug discovery, development, and regulation	1979	Wardell, William M.
The use of pharmaceutical profitability measures for public policy actions	1979	Clarkson, Kenneth W.
Rates of return to investment in the pharmaceutical industry : a survey and critical appraisal	1979	Brownlee, Oswald H.
Economic regulation of prescription drugs	1979	Virts, John R.
The impact of regulation on new drug development	1979	Wardell, William M.
The pharmaceutical development process : estimates of development costs and times and the effects of proposed regulatory changes	1979	Hansen, Ronald W.
New studies on market definition, concentration, theory of supply, entry, and promotion	1979	Grabowski, Henry G.
A summary and critique of economic studies of the ethical drug industry : 1962-1968	1979	Jadlow, Joseph M.
Pricing of multiple-source drugs	1979	Schwartzman, David
The effect of national health insurance on the economics of the drug industry	1979	Chien, Robert I.
Pricing in the pharmaceutical industry in the United Kingdom and the United States	1979	Reekie, W. Duncan
The economic consequences of regulating without regard to economic consequences	1979	Brownlee, Oswald H.
Competition in the pharmaceutical industry	1979	Comanor, William S.